CagA seropositivity in Helicobacter pylori positive patients with psoriasis [14]

Journal of the European Academy of Dermatology and Venereology

Volumn 18, Issue 1, 2004, Pages 116-117

  Dauden E ^a   Cabrera, M M ^a   Onate M J ^b   Pajares, J M ^a   Garcia Diez A ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b Centro de Salud Fuencarral   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CAGA PROTEIN; CYCLOSPORIN; ETRETIN; VIRULENCE FACTOR;

ADOLESCENT; ADULT; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ERADICATION THERAPY; FEMALE; GENE EXPRESSION; HELICOBACTER INFECTION; HUMAN; LETTER; MALE; OUTCOMES RESEARCH; PEPTIC ULCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PSORIASIS; PSORIATIC ARTHRITIS; SEROPREVALENCE; STOMACH CANCER; WESTERN BLOTTING;

ADOLESCENT; ADULT; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSORIASIS; SEROEPIDEMIOLOGIC STUDIES;

EID: 0742289592     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2004.00879.x     Document Type: Letter

References (13)

1. Wedi B, Kapp A. Helicobacter pylori infection in skin disease: a critical appraisal. Am J Clin Dermatol 2002; 3: 273-282.
2. Halasz CLG. Helicobacter pylori antibodies in patients with psoriasis. Arch Dermatol 1996; 132: 95-96.
3. Daudén E, Vázquez-Carrasco MA, Peñas PF et al. Association of Helicobacter pylori infection with psoriasis and lichen planus: prevalence and effect of eradication therapy. Arch Dermatol 2000; 136: 1275-1276.
4. Fabrizi G, Carbone A, Lippi ME et al. Lack of evidence of relationship between Helicobacter pylori infection and psoriasis in childhood. Arch Dermatol 2001; 137: 1529.
5. Figura N. Identifiable Helicobacter strains of factors important in the development of duodenal ulcer disease. Helicobacter 1997; 2: S3-S12.
6. Shimoyama T, Fukuda S, Tanaka M et al. CagA seropositivity associated with development of gastric cancer in a Japanese population. J Clin Pathol 1998; 51: 225-228.
7. Figura N, Di Cairano G Lore F et al. The infection by Helicobacter pylori strains expressing Cag A is highly prevalent in women with autoimmune thyroid disorders. J Physiol Pharmacol 1999; 50: 817-826.
8. Szlachcic A, Sliwowski Z, Karczwewska E et al. Helicobacter pylori and its eradication in rosacea. J Physiol Pharmacol 1999; 50: 777-786.
9. Gunn M, Stephens JC, Thompson JR et al. Significant association of CagA positive Helicobacter pylori strains with risk of premature myocardial infarction. Heart 2000; 84: 267-271.
10. Ching CK, Wong BCY, Kwok E et al. Prevalence of CagA-bearing Helicobacter pylori strains detected by the anti-CagA assay in patients with peptic ulcer disease and in controls. Am J Gastroenterol 1996; 91: 949-953.
11. Weel JFL, Van der Hulst RWM, Gerrits Y et al. The interrelationship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori-related diseases. J Infect Dis 1996; 173: 1171-1175.
12. Parente F, Imbesi V, Maconi G et al. Influence of bacterial status on gastritis, gastric function indices, and pattern of symptoms in H. pylori-positive dyspeptic patients. Am J Gastroenterol 1998; 93: 1073-1079.
13. Danesh J, Whincup P, Walker M et al. High prevalence of potentially virulent strains of Helicobacter pylori in the general male British population. Gut 2000; 47: 23-25.